Pacific Biosciences of California(PACB) - 2025 Q3 - Quarterly Results
Third quarter results: | | Q3 2025 | Q3 2024 | | --- | --- | --- | | Revenue | 40.0 million | | Instrument revenue | 16.8 million | | Consumable revenue | 18.5 million | | Service and other revenue | 4.7 million | | TM Revio systems | 13 | 22 | | TM Vega systems | 32 | — | | Annualized Revio pull-through per system | ~255,000 | | Cash, cash equivalents, and investments | 471.1 million | Gross margin, operating ...